Fennec Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Fennec Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Fennec Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fennec Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $348k | 31k | 11.22 |
| 2023-09-30 | $130k | 17k | 7.51 |
| 2023-06-30 | $272k | 31k | 8.83 |
| 2023-03-31 | $173k | 21k | 8.32 |
| 2022-12-31 | $202k | 21k | 9.60 |
| 2022-06-30 | $56k | 10k | 5.58 |
| 2022-03-31 | $73k | 13k | 5.58 |
| 2021-12-31 | $59k | 13k | 4.39 |
| 2021-09-30 | $127k | 13k | 9.46 |
| 2021-03-31 | $131k | 21k | 6.22 |
| 2020-12-31 | $184k | 25k | 7.46 |
| 2020-09-30 | $150k | 25k | 6.05 |
| 2020-06-30 | $255k | 31k | 8.34 |
| 2019-12-31 | $92k | 14k | 6.47 |
| 2018-09-30 | $86k | 10k | 8.24 |
| 2018-06-30 | $177k | 17k | 10.42 |
| 2018-03-31 | $218k | 18k | 12.11 |